Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The levels of prostate-specific antigen in the blood can indicate further testing is needed to screen for cancer.
“I am living proof that early detection can save lives,” Tigerlily CEO Maimah Karmo said at the NCCN cancer policy summit.
The largest peer-reviewed study of the Pfizer-BioNTech COVID vaccine in cancer patients finds no more, and no different, side effects.
National Comprehensive Cancer Network’s new patient guide covers effective tools for preventing and early detection of colorectal cancer.
People living with cancer are at higher risk for severe illness and death due to COVID-19.
New study reveals that more work is needed to enhance adherence to recommended cancer screening in Canada.
New NCCN guidelines explain how to recognize and manage immunotherapy-related toxicities.
COVID-19 has disrupted care and raised treatment safety concerns. These trustworthy sources can help you stay up to date.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.